Experience with 35 needleless implants (Hemasite) in 27 patients over the past 27 months has shown that this device can provide immediately available painless access in patients lacking adequate veins for a direct internal fistula for hemodialysis. The cumulative patency rate of 46% at two years is comparable to that of polytetrafluoroethylene grafts. The major complication was infection which contributed to graft loss in one third of patients. Obese female patients were particularly susceptible to infection and had a worse graft prognosis. Long-term results with a graftless model were poor.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007611-198412000-00007 | DOI Listing |
Publication Analysis
Top Keywords
experience needleless
8
needleless vascular
4
vascular access
4
access device
4
device hemasite
4
hemasite hemodialysis
4
hemodialysis experience
4
needleless implants
4
implants hemasite
4
patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!